Concepedia

Preemptive interferon-α therapy could prevent relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: A real-world analysis

Shuang Fan, Tianzhong Pan, Liping Dou, Yanmin Zhao, Xiaohui Zhang, Lan‐Ping Xu, Yu Wang, Xiao‐Jun Huang, Xiao‐Dong Mo

Frontiers in Immunology · 2023 · 15 citations · 48 references

DOIFull text

Open access

Abstract

Thus, real-world data suggest that preemptive IFN-α is effective for treating patients with AML with MRD after allo-HSCT.

References

48

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

Madan Jagasia, Hildegard Greinix, Mukta Arora et al. · Biology of Blood and Marrow Transplantation · 2014 · 5.2K citations · Full text

, , +17

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

Courtney D. DiNardo, Brian A. Jonas, Vinod Pullarkat et al. · New England Journal of Medicine · 2020 · 2.6K citations · Full text

International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

Andrew C. Harris, Rachel Young, Steven M. Devine et al. · Biology of Blood and Marrow Transplantation · 2015 · 882 citations · Full text

Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial

Andrew H. Wei, Pau Montesinos, Vladimir Ivanov et al. · Blood · 2020 · 725 citations · Full text

Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study

Yu Wang, Qifa Liu, Lan‐Ping Xu et al. · Blood · 2015 · 478 citations · Full text